Under construction – not a live service
Sign in
Taking people in South KoreaNo phase

Studies blood clots removed from the brain in people with stroke

Studies clots removed during stroke treatment to learn causes and predict future events.

Plain-language title generated from the registry record
Registry title: Thrombus Analysis of Ischemic Stroke

Key facts

Where
Seoul, South KoreaSee the site

Where in South Korea

  • Seoul National University HospitalSeoul, South KoreaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Seoul National University Hospital
Trial code
NCT07043413
Record updated
29 June 2025
Original description
Patients with acute ischemic stroke who have undergone endovascular thrombectomy will be eligible to be included, and thrombus will be collected after obtaining informed consent. Enrolled patients will receive a comprehensive diagnostic evaluation and the best medical treatment according to recent stroke management guidelines. The mechanism of the stroke will be classified into atherosclerotic, cardiac embolism, others and unknown causes based on diagnostic workup. Patients will be monitored in an outpatient clinic for vascular events including stroke recurrence, death, and bleeding events, which will continue for up to two years after the initial stroke event. Thrombus information related to RNA expression patterns and histological characteristics will be analyzed to classify the stroke mechanism and predict future vascular events after the initial stroke.Read full original descriptionShow less

Thrombus Analysis of Ischemic Stroke

Patients with acute ischemic stroke who have undergone endovascular thrombectomy will be eligible to be included, and thrombus will be collected after obtaining informed consent. Enrolled patients will receive a comprehensive diagnostic evaluation and the best medical treatment according to recent stroke management guidelines. The mechanism of the stroke will be classified into atherosclerotic, cardiac embolism, others and unknown causes based on diagnostic workup. Patients will be monitored in an outpatient clinic for vascular events including stroke recurrence, death, and bleeding events, which will continue for up to two years after the initial stroke event. Thrombus information related to RNA expression patterns and histological characteristics will be analyzed to classify the stroke mechanism and predict future vascular events after the initial stroke.

Inclusion: patients with acute ischemic stroke who had undergone endovascular thrombectomy.

Exclusion: -.

ClinicalTrials.gov NCT07043413